Showing results (111-120 of 277) with videos related to
Sort By:
Pageof 28
Clinical Science and Molecular Medicine|November 1, 1975
Urinary excretion of 17-oxosteroids in hereditary coproporphyriaJ W Paxton, M R Moore, A D Beattie, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1989
Action of lead on neurotransmission in ratsM J McIntosh, P A Meredith, M R Moore, et al.Neuropharmacology|February 1, 1986
Effects of lead in the laboratory mouse--2. Development and social behaviour after lifelong administration of a small dose of lead acetate in drinking fluidJ M Donald, M G Cutler, M R Moore, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|June 1, 2000
Chronic toxicity of di(2-ethylhexyl)phthalate in ratsR M David, M R Moore, D C Finney, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|December 2, 2000
Chronic toxicity of di(2-ethylhexyl)phthalate in miceR M David, M R Moore, D C Finney, et al.Toxicologic Pathology|September 19, 2001
Reversibility of the chronic effects of di(2-ethylhexyl)phthalateR M David, M R Moore, D C Finney, et al.European Journal of Clinical Pharmacology|November 14, 1977
The effects of industrial lead poisoning on cytochrome P450 mediated phenazone (antipyrine) hydroxylationP A Meredith, B C Campbell, M R Moore, et al.Journal of Psychopharmacology (Oxford, England)|February 3, 2012
Lofepramine--a safe anti-depressant in acute hepatic porphyria?S B Dover, A Graham, M R Moore, et al.Gut|August 1, 1994
Safety of general anaesthesia and surgery in acute hepatic porphyriaS B Dover, L Plenderleith, M R Moore, et al.Cancer Treatment Reports|July 1, 1976
Phase I trial of dianhydrogalactitol administered Iv in a weekly scheduleC L Vogel, E F Winton, M R Moore, et al.Pageof 28